查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1934316

醫療保健和生命科學領域自然語言處理市場—全球產業規模、佔有率、趨勢、機會和預測：按組件、NLP 類型、部署模式、最終用戶、地區和競爭格局分類，2021-2031 年

NLP in Healthcare & Life Sciences Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component, By NLP Type, By Deployment Mode, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球醫療保健和生命科學領域的自然語言處理市場預計將從 2025 年的 31.7 億美元成長到 2031 年的 53.4 億美元，複合年成長率為 9.09%。

此領域利用計算演算法，從電子健康記錄、醫療記錄和科學文獻等非結構化資料來源解讀、理解並產生人類語言。推動市場成長的根本動力源自於以下兩方面：一是迫切需要透過自動化文件來減輕臨床醫師的職業倦怠；二是企業需要從龐大的醫學文本庫中提取可操作的洞見。這種結構性需求是市場擴張的核心驅動力，而非短暫的科技趨勢。根據醫療集團管理協會（Medical Group Management Association）預測，到2024年，“59%的醫療集團領導者將把速記和文件工具視為他們面臨的首要人工智慧挑戰。”

市場概覽
預測期 2027-2031
市場規模：2025年 31.7億美元
市場規模：2031年 53.4億美元
複合年成長率：2026-2031年 9.09%
成長最快的細分市場 解決方案
最大的市場 北美洲

然而，市場在資料隱私和監管合規方面面臨許多重大障礙。在滿足嚴格法律標準的同時保護敏感的患者資訊是一項複雜的任務，它會帶來巨大的責任風險和互通性挑戰。這些障礙可能會阻礙自然語言處理技術在醫療保健領域的廣泛應用。

市場促進因素

生成式人工智慧和大規模語言模型的進步是目前推動全球醫療保健和生命科學自然語言處理（NLP）市場變革的最重要力量。與傳統NLP不同，這些技術能夠產生更高級的臨床文件並自動總結患者病史。隨著醫療服務提供者尋求利用這些工具來改善診斷支援和最佳化工作流程，這項技術飛躍正在推動醫療機構的快速應用。根據美國醫學會（AMA）於2025年2月進行的增強智慧調查，到2024年，66%的醫生將在實踐中使用人工智慧，幾乎是前一年的兩倍。這一成長是由專業人士態度的轉變所推動的。正如VatorNews在2025年2月發表的報導《AMA：到2024年，使用人工智慧的醫生人數幾乎加倍》中所述，36%的醫生表示對人工智慧感到興奮多於擔憂，這表明市場對這些先進功能的需求強勁。

提高營運效率和控制醫療成本是第二個關鍵促進因素，它直接應對了醫護人員倦怠和行政負擔過重等結構性挑戰。隨著醫療機構面臨財務壓力，它們擴大採用自然語言處理 (NLP) 解決方案來自動化醫療編碼、收入週期管理和即時文件等勞動密集型任務。這些工具減輕了醫護人員的認知負擔，使他們能夠專注於患者照護而非資料輸入。根據 Elsevier 於 2025 年 7 月發布的《未來臨床醫生 2025》報告，57% 的臨床醫生認為臨床人工智慧工具可以節省他們的時間。透過簡化行政工作流程，NLP 應用不僅提高了營運效率，還有助於確保醫療服務系統在日益資料密集的環境中永續性。

市場挑戰

嚴格的資料隱私保護和監管合規要求對全球醫療保健和生命科學領域的自然語言處理（NLP）市場擴張構成了重大障礙。醫療機構在嚴格的法律體制下運營，這些框架要求絕對保護病患隱私。為了有效運行，NLP系統需要存取大量的非結構化臨床記錄數據，這本身就存在洩露個人識別資訊（PII）的風險。資料外洩可能帶來的高昂代價和巨額監管罰款迫使醫療機構採取規避風險的策略，從而顯著延緩了這些技術的採購和整合。

這種營運上的謹慎態度正在阻礙市場成長，因為決策者優先考慮的是規避責任而非技術能力。對違規的擔憂使得醫療服務提供者不願在其網路中推廣自然語言處理（NLP）解決方案，通常將計劃限制在小規模、孤立的試點階段。這種猶豫不決也體現在近期關於採用標準的行業調查結果中：根據美國醫學會2024年的調查，「87%的醫生認為數據隱私保障是推動人工智慧工具普及的最重要因素。」這一數據凸顯了行業內持續存在的合規性問題仍在阻礙著NLP解決方案的廣泛商業化。

市場趨勢

利用自然語言處理（NLP）加速藥物研發和識別生物標記物，正將市場關注點從行政自動化轉向科學研究。製藥公司正利用演算法預測分子交互作用，並從海量的科學文獻和基因組數據中識別潛在的治療標靶。這種轉變使研究人員能夠縮短藥物研發的早期階段，並顯著減少將新治療方法推進到臨床試驗所需的時間。根據英偉達（NVIDIA）於2025年7月發布的《醫療保健和生命科學領域人工智慧現狀：2025年趨勢》調查，59%的製藥和生物技術專業人士表示，他們採用人工智慧的主要目的是進行藥物研發，這凸顯了計算生物學在該行業中的重要性。

透過自動化患者配對簡化臨床試驗參與者招募流程，正在消除生命科學研究中一個關鍵的參與者招募瓶頸。自然語言處理 (NLP) 引擎正擴大整合到臨床工作流程中，用於解析非結構化的電子健康記錄和病理報告，從而根據複雜的篩選標準自動識別合格的候選人。這項功能確保了患者群的準確性，同時最大限度地減少了招募失敗而造成的代價高昂的延誤。這一趨勢正在推動其廣泛應用；根據 Medidata 於 2025 年 10 月發布的報告《人工智慧在臨床試驗中的現狀與未來》，83% 在臨床試驗中使用人工智慧的公司正在使用該技術，特別是用於患者群體和隊列識別。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章：全球醫療保健與生命科學自然語言處理市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按組件（解決方案、服務）
    • 依自然語言處理類型（基於規則的自然語言處理、統計自然語言處理、混合自然語言處理）
    • 依部署類型（本機部署、雲端部署）
    • 依最終使用者（公共衛生/政府機構、醫療設備、健康保險、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美醫療保健與生命科學自然語言處理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲醫療保健與生命科學自然語言處理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區醫療保健與生命科學自然語言處理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲醫療保健和生命科學領域自然語言處理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲醫療保健與生命科學自然語言處理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

13. 全球醫療保健與生命科學領域自然語言處理市場：SWOT 分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • SAS Institute Inc.
  • IBM Corporation
  • Microsoft Corporation
  • Google LLC
  • IQVIA Inc
  • Oracle Corporation
  • Inovalon
  • Dolbey Systems, Inc.
  • Averbis GmbH

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23488

The Global NLP in Healthcare & Life Sciences Market is projected to expand from USD 3.17 Billion in 2025 to USD 5.34 Billion by 2031, registering a CAGR of 9.09%. This field involves the use of computational algorithms to interpret, understand, and generate human language from unstructured sources like electronic health records, clinical notes, and scientific literature. The market's fundamental growth is driven by the critical need to alleviate clinician burnout through automated documentation and the operational requirement to extract actionable insights from massive repositories of medical text. These structural necessities distinguish the market's core expansion from temporary technological trends. According to the 'Medical Group Management Association', in '2024', '59% of medical group leaders identified scribing and documentation tools as their top artificial intelligence priority'.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.17 Billion
Market Size 2031USD 5.34 Billion
CAGR 2026-20319.09%
Fastest Growing SegmentSolutions
Largest MarketNorth America

However, the market faces significant hurdles regarding data privacy and the complexity of regulatory compliance. The intricate task of securing sensitive patient information while satisfying rigorous legal standards introduces major liability risks and interoperability challenges. These obstacles threaten to impede the widespread scaling of NLP technologies across the healthcare sector.

Market Driver

Advancements in Generative AI and Large Language Models constitute the most transformative force currently reshaping the Global NLP in Healthcare & Life Sciences Market. Unlike traditional NLP, these technologies allow for the sophisticated generation of clinical documentation and automated summarization of patient histories. This technological leap has sparked rapid adoption across medical practices as providers aim to leverage these tools for improved diagnostic support and workflow optimization. According to the American Medical Association's 'Augmented Intelligence Research' survey from February 2025, 66% of physicians reported using AI in their practices in 2024, a figure that nearly doubled from the previous year. This surge is supported by changing professional sentiment; as noted by VatorNews in February 2025, in the 'AMA: physicians using AI nearly doubled in 2024' article, 36% of physicians reported feeling more excited than concerned about AI, indicating a strong market appetite for these advanced capabilities.

The imperative for operational efficiency and healthcare cost containment serves as the second critical driver, directly addressing the systemic challenges of clinician burnout and administrative overload. As healthcare organizations confront mounting financial pressures, NLP solutions are increasingly deployed to automate labor-intensive tasks such as medical coding, revenue cycle management, and real-time documentation. These tools reduce the cognitive load on practitioners, allowing them to redirect their focus from data entry to patient care. According to the 'Clinician of the Future 2025' report by Elsevier in July 2025, 57% of clinicians perceive clinical AI tools as saving them time. By streamlining administrative workflows, NLP applications not only improve operational margins but also help ensure the sustainability of healthcare delivery systems in an increasingly data-dense environment.

Market Challenge

The strict enforcement of data privacy and regulatory compliance acts as a substantial barrier to the expansion of the Global NLP in Healthcare and Life Sciences Market. Healthcare organizations function under rigorous legal frameworks that mandate the absolute protection of patient confidentiality. Because NLP systems require access to vast datasets of unstructured clinical notes and records to operate effectively, there is an inherent risk of exposing Personally Identifiable Information (PII). The potential for costly data breaches and heavy regulatory fines compels institutions to adopt a risk-averse approach, significantly slowing the procurement and integration of these technologies.

This operational caution creates a bottleneck for market growth, as decision-makers prioritize liability protection over technological capabilities. The fear of non-compliance limits the willingness of providers to scale NLP solutions across their networks, often confining projects to small, isolated pilots. This reluctance is reflected in recent industry findings regarding adoption criteria. According to the 'American Medical Association', in '2024', '87% of physicians identified data privacy assurances as a top attribute required to advance the adoption of artificial intelligence tools'. This statistic underscores that widespread commercialization remains hindered by deep-seated compliance anxieties within the sector.

Market Trends

The utilization of NLP to accelerate drug discovery and biomarker identification is shifting the market focus from administrative automation to scientific research. Pharmaceutical companies are deploying algorithms to mine vast repositories of scientific literature and genomic data to predict molecular interactions and identify potential therapeutic targets. This transition enables researchers to compress the initial stages of drug development, significantly reducing the time required to bring new therapies to clinical testing. According to NVIDIA, July 2025, in the 'State of AI in Healthcare and Life Sciences: 2025 Trends' survey, 59% of pharma and biotech professionals identified drug discovery as their primary AI goal, underscoring the sector's prioritization of computational biology.

The enhancement of clinical trial recruitment via automated patient matching is addressing the critical bottleneck of participant enrollment in life sciences research. NLP engines are increasingly integrated into clinical workflows to parse unstructured electronic health records and pathology reports, automatically identifying eligible candidates based on complex inclusion criteria. This capability ensures accurate patient cohorts while minimizing costly delays associated with recruitment failures. This trend is driving substantial adoption; according to Medidata, October 2025, in the 'The State of AI in Clinical Trials: Today and Tomorrow' report, 83% of companies using AI in clinical trials are now leveraging the technology specifically for patient population and cohort identification.

Key Market Players

  • SAS Institute Inc.
  • IBM Corporation
  • Microsoft Corporation
  • Google LLC
  • IQVIA Inc
  • Oracle Corporation
  • Inovalon
  • Dolbey Systems, Inc.
  • Averbis GmbH

Report Scope

In this report, the Global NLP in Healthcare & Life Sciences Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

NLP in Healthcare & Life Sciences Market, By Component

  • Solutions
  • Services

NLP in Healthcare & Life Sciences Market, By NLP Type

  • Rule-Based Natural Language Processing
  • Statistical Natural Language Processing
  • Hybrid Natural Language Processing

NLP in Healthcare & Life Sciences Market, By Deployment Mode

  • On-premises
  • Cloud

NLP in Healthcare & Life Sciences Market, By End User

  • Public Health & Government Agencies
  • Medical Devices
  • Healthcare Insurance
  • Others

NLP in Healthcare & Life Sciences Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global NLP in Healthcare & Life Sciences Market.

Available Customizations:

Global NLP in Healthcare & Life Sciences Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global NLP in Healthcare & Life Sciences Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Solutions, Services)
    • 5.2.2. By NLP Type (Rule-Based Natural Language Processing, Statistical Natural Language Processing, Hybrid Natural Language Processing)
    • 5.2.3. By Deployment Mode (On-premises, Cloud)
    • 5.2.4. By End User (Public Health & Government Agencies, Medical Devices, Healthcare Insurance, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America NLP in Healthcare & Life Sciences Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By NLP Type
    • 6.2.3. By Deployment Mode
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States NLP in Healthcare & Life Sciences Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By NLP Type
        • 6.3.1.2.3. By Deployment Mode
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada NLP in Healthcare & Life Sciences Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By NLP Type
        • 6.3.2.2.3. By Deployment Mode
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico NLP in Healthcare & Life Sciences Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By NLP Type
        • 6.3.3.2.3. By Deployment Mode
        • 6.3.3.2.4. By End User

7. Europe NLP in Healthcare & Life Sciences Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By NLP Type
    • 7.2.3. By Deployment Mode
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany NLP in Healthcare & Life Sciences Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By NLP Type
        • 7.3.1.2.3. By Deployment Mode
        • 7.3.1.2.4. By End User
    • 7.3.2. France NLP in Healthcare & Life Sciences Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By NLP Type
        • 7.3.2.2.3. By Deployment Mode
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom NLP in Healthcare & Life Sciences Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By NLP Type
        • 7.3.3.2.3. By Deployment Mode
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy NLP in Healthcare & Life Sciences Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By NLP Type
        • 7.3.4.2.3. By Deployment Mode
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain NLP in Healthcare & Life Sciences Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By NLP Type
        • 7.3.5.2.3. By Deployment Mode
        • 7.3.5.2.4. By End User

8. Asia Pacific NLP in Healthcare & Life Sciences Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By NLP Type
    • 8.2.3. By Deployment Mode
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China NLP in Healthcare & Life Sciences Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By NLP Type
        • 8.3.1.2.3. By Deployment Mode
        • 8.3.1.2.4. By End User
    • 8.3.2. India NLP in Healthcare & Life Sciences Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By NLP Type
        • 8.3.2.2.3. By Deployment Mode
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan NLP in Healthcare & Life Sciences Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By NLP Type
        • 8.3.3.2.3. By Deployment Mode
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea NLP in Healthcare & Life Sciences Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By NLP Type
        • 8.3.4.2.3. By Deployment Mode
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia NLP in Healthcare & Life Sciences Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By NLP Type
        • 8.3.5.2.3. By Deployment Mode
        • 8.3.5.2.4. By End User

9. Middle East & Africa NLP in Healthcare & Life Sciences Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By NLP Type
    • 9.2.3. By Deployment Mode
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia NLP in Healthcare & Life Sciences Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By NLP Type
        • 9.3.1.2.3. By Deployment Mode
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE NLP in Healthcare & Life Sciences Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By NLP Type
        • 9.3.2.2.3. By Deployment Mode
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa NLP in Healthcare & Life Sciences Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By NLP Type
        • 9.3.3.2.3. By Deployment Mode
        • 9.3.3.2.4. By End User

10. South America NLP in Healthcare & Life Sciences Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By NLP Type
    • 10.2.3. By Deployment Mode
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil NLP in Healthcare & Life Sciences Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By NLP Type
        • 10.3.1.2.3. By Deployment Mode
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia NLP in Healthcare & Life Sciences Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By NLP Type
        • 10.3.2.2.3. By Deployment Mode
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina NLP in Healthcare & Life Sciences Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By NLP Type
        • 10.3.3.2.3. By Deployment Mode
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global NLP in Healthcare & Life Sciences Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. SAS Institute Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. IBM Corporation
  • 15.3. Microsoft Corporation
  • 15.4. Google LLC
  • 15.5. IQVIA Inc
  • 15.6. Oracle Corporation
  • 15.7. Inovalon
  • 15.8. Dolbey Systems, Inc.
  • 15.9. Averbis GmbH

16. Strategic Recommendations

17. About Us & Disclaimer